報價延遲最少15分鐘:2026/04/21 21:21 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
14.93 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.81/-0.29
|
|
企業價值
96.86M
|
| 資產負債 |
|
每股賬面淨值
2.18
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
1.36M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatmentparadigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment. |
